Oncology

Combined biopsy, including magnetic resonance imaging (MRI)-targeted and systematic biopsy, leads to more detection of prostate cancers among patients with MRI-visible lesions, according to a study published in the March 5 issue of the New England Journal of Medicine. Michael Ahdoot, M.D., from the National Institutes of Health in Bethesda, Maryland, and colleagues examined whether biopsies...

For men with intermediate- and high-risk prostate adenocarcinoma, 10-year outcomes are similar with conventionally fractionated intensity-modulated radiation therapy (C-IMRT) or moderate hypofractionated IMRT (H-IMRT), according to a study published online March 2 in the Journal of Clinical Oncology. Vladimir Avkshtol, M.D., from Fox Chase Cancer Center in Philadelphia, and colleagues presented 10-year disease outcomes for men...

MDNewsline recently interviewed international urologic surgeon, Dr. Howard Aubert, to discuss the effects of prostate cancer on African American patients. Dr. Aubert currently practices in Riverside, CA, and specializes in prostate, kidney, bladder, testicular cancer, incontinence, infertility, BPH, and low T. MDNewsline: Dr. Aubert, what are some of the biggest differences in the way prostate...

African-American (AFR) men with prostate cancer have distinct genomic alterations from European-American (EUR) men, according to a study published online July 10 in Clinical Cancer Research. Yusuke Koga, from the Boston University School of Medicine, and colleagues compared the frequencies of somatic alterations in prostate cancer obtained from four datasets comprising 250 AFR and 611 EUR...

Several studies have documented that African American men are far more likely than non-Hispanic white men to die of prostate cancer. Other studies have shown that Hispanic women are more likely to be diagnosed with cervical cancer than non-Hispanic white women. Do disparities like these reflect differences in health insurance status, diet, genetics, or a...

Dr. Keith Crawford, Director of Clinical Trials and Patient Education at the Prostate Health Education Network, discusses new treatments and clinical trials in this PHEN TV production. Visit our partners at PHEN at http://prostatehealthed.org/ today for more  expert insights on prostate cancer, clincial trials, and treatments.

Testing without the traditional office visits and counseling poses no additional stress to women THURSDAY, June 4, 2020 (HealthDay News) — Women at risk for hereditary breast and ovarian cancer (HBOC) who undergo genetic testing without receiving pretest and posttest counseling and only receive electronic education are at no increased risk for posttest stress, according...

Tumors from black women with invasive breast cancer have higher expression of the insulin receptor June 1, 2020 (HealthDay News) — Insulin resistance is one factor mediating part of the association between race and poor prognosis in breast cancer, according to a study published online May 12 in Breast Cancer Research. Emily J. Gallagher, M.D., from...

Only complete eradication of Helicobacter pylori infection, not treatment alone, will reduce the risk for developing stomach cancer, according to a study recently published in Gastroenterology. Shria Kumar, M.D., from the Perelman School of Medicine at the University of Pennsylvania in Philadelphia, and colleagues evaluated data for 371,813 patients from the Veterans Health Administration (median age, 62 years;...